High Coronary Artery Calcium in Type 1 Diabetes Patients Despite Good Control, Study Finds

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2025-08-27 03:30 GMT | Update On 2025-08-27 05:19 GMT

USA: People living with type 1 diabetes for more than 50 years continue to face significant risks of cardiovascular disease (CVD), even when their kidney function is preserved and metabolic control is excellent, according to a new study published in Diabetologia by Marc Gregory Yu and colleagues at the Joslin Diabetes Center.

The research focused on the Joslin “Medalists,” a unique group of individuals who have managed type 1 diabetes for at least half a century. Despite optimal cardiometabolic management—average blood pressure at 132/64 mmHg, LDL cholesterol of 2.10 mmol/l, HDL cholesterol of 1.69 mmol/l, and median HbA1c of 7.1%—these participants displayed a strikingly high burden of coronary atherosclerosis.

Based on the study, the researchers reported the following findings:

Among 1,038 participants analyzed, 40% reported cardiovascular disease, while 32% had diabetic kidney disease (DKD).
Coronary artery calcium (CAC) scoring was performed in 142 participants, and cardiac magnetic resonance imaging (CMR) in 111.
The median CAC score was 937, with no significant difference between those with and without DKD (1,136 vs. 878, respectively).
In individuals without DKD, HbA1c was significantly associated with cardiovascular disease risk (odds ratio 1.40).
Neither hypoglycemia nor glycemic variability showed significant associations with cardiovascular disease.
Osteopontin (OPN) was the only inflammatory biomarker independently linked to cardiovascular disease in this subgroup (β = 0.50).

In the study, DKD did not appear to be a major driver of coronary atherosclerosis in this highly resilient cohort, likely due to relatively mild kidney impairment and survivor bias—these participants represent individuals who have endured type 1 diabetes for decades with relatively good health. The researchers acknowledged that their study’s cross-sectional design and smaller subgroup sizes may limit the generalizability of findings.

Still, the findings raise critical clinical implications. “Even in individuals with long-standing type 1 diabetes and excellent cardiometabolic profiles, a high coronary calcium burden persists,” the authors noted. This suggests that controlling hyperglycemia and reducing inflammation—particularly targeting osteopontin—could be essential strategies for mitigating cardiovascular risk in this population.

The study emphasizes the importance of comprehensive cardiovascular screening in aging individuals with type 1 diabetes, including routine imaging and biomarker assessments, regardless of kidney status. While further longitudinal studies are needed, the evidence underscores that exceptional glycemic control alone may not eliminate heart disease risk in those with decades-long diabetes.

As Yu and colleagues conclude, a proactive approach addressing both blood glucose and inflammation, alongside continued research into biomarkers like osteopontin, could be key to improving outcomes for people living with type 1 diabetes well into later life.

Reference:

Yu, M.G., Shah, H., Jangolla, S. et al. Risk and protective factors for coronary atherosclerosis and myocardial dysfunction in individuals with long-duration type 1 diabetes. Diabetologia (2025). https://doi.org/10.1007/s00125-025-06521-4

Article Source : Diabetologia

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medha Baranwal

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

High Coronary Artery Calcium in Type 1 Diabetes Patients Despite Good Control, Study Finds

Similar News

Proactive Consideration of Metformin in Prediabetes-A Call of Action

Biocon Pharma bags tentative USFDA nod for diabetes medicine Sitagliptin

Mediterranean diet combined with calorie reduction and exercise may reduce diabetes risk by nearly one-third: Study

Prediabetes: Blood Sugar More Likely to Return to Normal Than Progress to Type 2 Diabetes, Global Study Finds

New Study Discovers Fat-Trapping Green Tea Beads for Safe Weight Loss

Study Reveals Your Brain Burns Fat at Night to Prevent Sugar Crashes

New study reveals Gender-Based Differences in Diabetes Outcomes